Submission Details
| 510(k) Number | K010201 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 22, 2001 |
| Decision Date | March 29, 2001 |
| Days to Decision | 66 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K010201 is an FDA 510(k) clearance for the BAYER ADVIA IMS SYSTEM, a Immunoassay Method, Troponin Subunit (Class II — Special Controls, product code MMI), submitted by Bayer Corp. (Tarrytown, US). The FDA issued a Cleared decision on March 29, 2001, 66 days after receiving the submission on January 22, 2001. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1215.
| 510(k) Number | K010201 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 22, 2001 |
| Decision Date | March 29, 2001 |
| Days to Decision | 66 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | MMI — Immunoassay Method, Troponin Subunit |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1215 |